These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 8329421)
1. A lactobionate-based extracellular-type solution for donor heart preservation. Shiiya N; Paul M; Benvenuti C; Astier A; Ferrer MJ; Loisance D J Heart Lung Transplant; 1993; 12(3):476-83. PubMed ID: 8329421 [TBL] [Abstract][Full Text] [Related]
2. Prolonged cardiac preservation. Evaluation of the University of Wisconsin preservation solution by comparison with the St. Thomas' Hospital cardioplegic solutions in the rat. Ledingham SJ; Katayama O; Lachno DR; Yacoub M Circulation; 1990 Nov; 82(5 Suppl):IV351-8. PubMed ID: 2225427 [TBL] [Abstract][Full Text] [Related]
3. Superiority of the University of Wisconsin solution over simple crystalloid for extended heart preservation. A study of left ventricular pressure-volume relationship. Ko W; Zelano JA; Lazzaro R; Lazenby WD; Hamilton T; Isom OW; Krieger KH J Thorac Cardiovasc Surg; 1992 May; 103(5):980-92. PubMed ID: 1569779 [TBL] [Abstract][Full Text] [Related]
4. Effects of calcium concentration, lactobionate content, and sodium/ potassium ratio of preservation solutions on resting left ventricular pressure and postreperfusion function of rabbit heterotopic heart transplants. Termignon JL; Pradier F; Petit A; Journois D; Weiss M; Mazmanian M J Heart Lung Transplant; 1995; 14(6 Pt 1):1126-35. PubMed ID: 8719460 [TBL] [Abstract][Full Text] [Related]
5. Donor heart preservation with a novel hyperpolarizing solution: superior protection compared with University of Wisconsin solution. Hoenicke EM; Sun X; Strange RG; Damiano RJ J Thorac Cardiovasc Surg; 2000 Oct; 120(4):746-54. PubMed ID: 11003758 [TBL] [Abstract][Full Text] [Related]
6. University of Wisconsin solution provides superior myocardial preservation compared with Stanford cardioplegic solution. Aziz S; Tada Y; Jaffery S; Mori Y; Reichenbach DD; Gronka R; Kushmerick M; Verrier ED J Heart Lung Transplant; 1994; 13(6):1099-108. PubMed ID: 7865517 [TBL] [Abstract][Full Text] [Related]
7. A comparison of UW cold storage solution and St. Thomas' solution II: a 31P NMR and functional study of isolated porcine hearts. Tian G; Smith KE; Biro GP; Butler KW; Haas N; Scott J; Anderson R; Deslauriers R J Heart Lung Transplant; 1991; 10(6):975-85. PubMed ID: 1756164 [TBL] [Abstract][Full Text] [Related]
8. The effects of Ca++ on the preservation of myocardial energy and function with University of Wisconsin solution. A 31P nuclear magnetic resonance study of isolated blood perfused Langendorff pig hearts. Tian G; Biro GP; Butler KW; Xiang B; Vu C; Deslauriers R J Heart Lung Transplant; 1993; 12(1 Pt 1):81-8. PubMed ID: 8443206 [TBL] [Abstract][Full Text] [Related]
11. Compositional analysis of a modified University of Wisconsin solution for extended myocardial preservation. A study of the left ventricular pressure-volume relation. Ko W; Zelano JA; Lazenby WD; Isom OW; Krieger KH Circulation; 1992 Nov; 86(5 Suppl):II326-32. PubMed ID: 1424021 [TBL] [Abstract][Full Text] [Related]
12. A comparison of intracellular solutions for donor heart preservation. Hendry PJ; Labow RS; Keon WJ J Thorac Cardiovasc Surg; 1993 Apr; 105(4):667-73. PubMed ID: 8469000 [TBL] [Abstract][Full Text] [Related]
14. A comparative study of cardiac preservation with Celsior or University of Wisconsin solution with or without prior administration of cardioplegia. Boku N; Tanoue Y; Kajihara N; Eto M; Masuda M; Morita S J Heart Lung Transplant; 2006 Feb; 25(2):219-25. PubMed ID: 16446224 [TBL] [Abstract][Full Text] [Related]
15. University of Wisconsin solution versus crystalloid cardioplegia for human donor heart preservation. A randomized blinded prospective clinical trial. Jeevanandam V; Barr ML; Auteri JS; Sanchez JA; Fong J; Schenkel FA; Marboe CC; Michler RE; Smith CR; Rose EA J Thorac Cardiovasc Surg; 1992 Feb; 103(2):194-8; discussion 198-9. PubMed ID: 1735983 [TBL] [Abstract][Full Text] [Related]
16. Reduced production of the deleterious hydroxyl free radical during the final reperfusion of isolated rabbit heart with the use of an improved sodium lactobionate-based cardioplegic medium. Charloux C; Ishii K; Paul M; Loisance D; Astier A J Heart Lung Transplant; 1994; 13(3):481-8. PubMed ID: 8061025 [TBL] [Abstract][Full Text] [Related]
17. Incomplete recovery of working heart function after twenty-four-hour preservation with a modified University of Wisconsin solution. Smolens IA; Follette DM; Berkoff HA; Castellanos LM; Segel LD J Heart Lung Transplant; 1995; 14(5):906-15. PubMed ID: 8800727 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of oxygenated University of Wisconsin solution containing endothelin-A receptor antagonist in twenty-four-hour heart preservation. Okada K; Yamashita C; Okada M; Okada M J Heart Lung Transplant; 1996 May; 15(5):475-84. PubMed ID: 8771503 [TBL] [Abstract][Full Text] [Related]
19. Liver transplantation from non-heart beating donors in rats: influence of viscosity and temperature of initial flushing solutions on graft function. Tojimbara T; Wicomb WN; Garcia-Kennedy R; Burns W; Hayashi M; Collins G; Esquivel CO Liver Transpl Surg; 1997 Jan; 3(1):39-45. PubMed ID: 9377757 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of hypothermic heart preservation with University of Wisconsin solution in heterotopically and orthotopically transplanted canine hearts. Mori Y; Hirose H; Murakawa S; Yamada T; Ishikawa M J Heart Lung Transplant; 1994; 13(4):688-950. PubMed ID: 7947886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]